Correlation Between Serum TK1 and Pathological Remission of Breast Cancer With Neoadjuvant Chemotherapy
RecruitingOBSERVATIONAL
Enrollment
200
Participants
Timeline
Start Date
March 1, 2024
Primary Completion Date
February 28, 2026
Study Completion Date
February 28, 2026
Conditions
Breast NeoplasmsTK1
Interventions
OTHER
non-intervention
non-intervention
Trial Locations (1)
Unknown
RECRUITING
Yunnan Cancer Hospital, Kunming
All Listed Sponsors
lead
Yunnan Cancer Hospital
OTHER
NCT06509555 - Correlation Between Serum TK1 and Pathological Remission of Breast Cancer With Neoadjuvant Chemotherapy | Biotech Hunter | Biotech Hunter